It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Inflammatory cytokines are key signaling molecules that can promote an immune response, thus their RNA turnover must be tightly controlled during infection. Most studies investigate the RNA decay pathways in the cytosol or nucleoplasm but never focused on the nucleolus. Although this organelle has well-studied roles in ribosome biogenesis and cellular stress sensing, the mechanism of RNA decay within the nucleolus is not completely understood. Here, we report that the nucleolus is an essential site of inflammatory pre-mRNA instability during infection. RNA-sequencing analysis reveals that not only do inflammatory genes have higher intronic read densities compared with non-inflammatory genes, but their pre-mRNAs are highly enriched in nucleoli during infection. Notably, nucleolin (NCL) acts as a guide factor for recruiting cytosine or uracil (C/U)-rich sequence-containing inflammatory pre-mRNAs and the Rrp6-exosome complex to the nucleolus through a physical interaction, thereby enabling targeted RNA delivery to Rrp6-exosomes and subsequent degradation. Consequently, Ncl depletion causes aberrant hyperinflammation, resulting in a severe lethality in response to LPS. Importantly, the dynamics of NCL post-translational modifications determine its functional activity in phases of LPS. This process represents a nucleolus-dependent pathway for maintaining inflammatory gene expression integrity and immunological homeostasis during infection.
The nucleolus is the traditional site for ribosomal RNA biogenesis. Here, the authors find that the nucleolus is a site of inflammatory pre-mRNA turnover and elucidated how immune homeostasis can be maintained by controlling inflammatory gene expression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Yonsei University, Department of Systems Biology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
2 Yonsei University, Department of Systems Biology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); Yonsei University, Department of Biotechnology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); National Cancer Center, Division of Tumor Immunology, Research Institute, Goyang, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810)
3 National Institutes of Health, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute for Arthritis and Musculoskeletal and Skin Disease, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
4 Gangneung-Wonju National University, Department of Biology, College of Natural Sciences, Gangneung, South Korea (GRID:grid.411733.3) (ISNI:0000 0004 0532 811X)
5 Sungkyunkwan University, Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Seoul, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
6 Sungkyunkwan University, Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Seoul, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Medical Center, Samsung Genome Institute (SGI), Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613)
7 Gangneung-Wonju National University, Department of Biology, College of Natural Sciences, Gangneung, South Korea (GRID:grid.411733.3) (ISNI:0000 0004 0532 811X); Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Charleston, USA (GRID:grid.259828.c) (ISNI:0000 0001 2189 3475)
8 Yonsei University, Department of Biotechnology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
9 Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Charleston, USA (GRID:grid.259828.c) (ISNI:0000 0001 2189 3475)
10 National Cancer Center, Division of Tumor Immunology, Research Institute, Goyang, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810)